Journal Mobile Options
Table of Contents
Vol. 53, No. 1, 2007
Issue release date: December 2006

Mild Cognitive Impairment: What’s in a Name?

Dierckx E. · Engelborghs S. · De Raedt R. · De Deyn P.P. · Ponjaert-Kristoffersen I.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: Nowadays the term mild cognitive impairment (MCI) is used to fill the gap between cognitive changes associated with normal ageing and those associated with dementia. Despite some agreement in general definitions, MCI is still a heterogeneous clinical syndrome for which no DSM-IV criteria have yet been established. Criteria by Petersen et al. are presently the most applied in clinical practice. Moreover, little attention has been paid to the specific relation between MCI and depression. Objective: This review highlights some concerns about the concept of MCI and provides guidelines within the field of neuropsychology to solve them. In a second part, the paper focuses on the specific relationship between depression in the elderly and MCI. Results: We hypothesize that certain test instruments can be used to operationalize the criteria proposed by Petersen et al. Moreover, we suggest that cued recall might be of help to differentiate between progressive and non-progressive MCI. Concerning the specific relation between depression and MCI, we assume that elderly depression with concomitant cognitive problems can be seen as an MCI. Conclusion: The proposed adjustments and additions (neuropsychological instruments and the incorporation of depressive symptoms) in the diagnostic flowchart of Petersen may serve as useful tools for clinicians when making a diagnosis of MCI.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Petersen RC, Smith GE, Waring SC: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–308.
  2. Dubois B, Albert ML: Amnestic MCI or prodromal Alzheimer’s disease? Lancet Neurol 2004;3:246–248.
  3. Busse A, Bischkopf J, Riedel-Heller S, Angermeyer MC: Mild cognitive impairment: prevalence and predictive validity according to current approaches. Acta Neurol Scand 2003;108:71–81.
  4. Visser PJ, Verhey FRJ, Ponds RWHM, Kester A, Jolles J: Distinction between preclinical Alzheimer’s disease and depression. J Am Geriatr Soc 2000;48:479–484.
  5. Van Dam D, De Deyn PP: Cognitive evaluation of disease-modifying efficacy of Galantamine and Memantine in the APP23 model. Eur Neuropsychopharmacol 2006;16:59–69.
  6. Meyer JS, XU G, Thornby J, Chowdhury M, Quach M: Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging. J Neurol Sci 2002;201:19–25.
  7. Palmer K, Jelic V, Winblad B: Preface: mild cognitive impairment. Acta Neurol Scand 2003;107:5–6.

    External Resources

  8. XU G, Meyer JS, By J, Chowdhury M, Quach M: Screening for mild cognitive impairment (MCI) utilizing combined mini-mental-cognitive capacity examinations for identifying dementia prodromes. Int J Geriatr Psychiatry 2002;17:1027–1033.
  9. DeCarli C: Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet 2003;2:15–21.

    External Resources

  10. Palmer K, Fratiglioni L, Winblad B: What is mild cognitive impairment? Variations in definitions and evolution of nondemented persons with cognitive impairment. Acta Neurol Scand 2003;107:14–20.

    External Resources

  11. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B: Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985–1992.
  12. Wahlund L-O, Pihlstrand E, Eriksdotter JM: Mild cognitive impairment: experience from a memory clinic. Acta Neurol Scand 2003;107:21–24.

    External Resources

  13. Kral VA: Senescent forgetfulness: benign and malignant. Can Med Assoc J 1962;86:257–260.
  14. Crook T, Bartus RT, Ferris SH: Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change: report of a National Institute of Mental Health Work group. Dev Neuropsychol 1986;2:261–276.

    External Resources

  15. Levy R: Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 1994;6:63–68.
  16. Canadian Study of Health and Aging: Canadian Study of Health and Aging working group: study methods and prevalence of dementia. Can Med Assoc J 1994;150:899–913.
  17. Bischkopf J, Busse A, Angermeyer MC: Mild cognitive impairment: a review of prevalence, incidence and outcome according to current approaches. Acta Psychiatr Scand 2002;106:403–414.
  18. Meyer JS, XU G, Thornby J, Chowdhury M, Quach M: Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging. J Neurol Sci 2002;201:19–25.
  19. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566–572.
  20. Reisberg B, Ferris SH, de Leon MJ, Crook T: The Global Deterioration Scale (GDS): an instrument for the assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1135–1139.
  21. Lautenschlager NT, Riemenschneider M, Drzezga A, Kurz AF: Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings. Dement Geriatr Cogn Disord 2001;12:379–386.
  22. Petersen RC, Morris JC: Clinical features; in Petersen RC (ed): Mild Cognitive Impairment: Aging to Alzheimer’s Disease. New York, Oxford University Press, Inc., 2003, pp 15–39.
  23. Busse A, Bischkopf J, Riedel-Heller SG, Angermeyer MC: Subclassifications for mild cognitive impairment: prevalence and predictive validity. Psychol Med 2003;33:1029–1038.
  24. Clarfield AM: The decreasing prevalence of reversible dementias – an updated meta-analysis. Arch Intern Med 2003;163:2219–2229.
  25. Shankle WR, Romney AK, Hara J, Fortier D, Dick MB, Chen JM, Chan T, Sun XJ: Methods to improve the detection of mild cognitive impairment. Proc Nat Acad Sci USA 2005;102:4919–4924.
  26. de Jager CA, Hogervorst E, Combrinck M, Budge MM: Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer’s disease. Psychol Med 2003;33:1039–1050.
  27. Palmer K, Bäckman L, Winblad B, Fratiglioni L: Detection of Alzheimer’s disease and dementia in the preclinical phase: population based cohort study. BMJ 2003;326:1–5.
  28. Small BJ, Mobly JL, Jonsson Laukka E, Jones S, Bäckman L: Cognitive deficits in preclinical Alzheimer’s disease. Acta Neurol Scand 2003;107:29–33.

    External Resources

  29. Luis CA, Loewenstein DA, Acevedo A, Barker WW, Duara R: Mild cognitive impairment – directions for future research. Neurology 2003;61:438–444.
  30. Jonker C, Geerlings MI, Schmand B: Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int J Geriatr Psychiatry 2000;15:983–991.
  31. Crum RM, Anthony JC, Bassett SS, Folstein MF: Population-based norms for the mini-mental state examination by age and educational level. JAMA 1993;269:2386–2391.
  32. Katz S, Ford A, Moskowitz R: Studies of illness in the aged. The index of ADL, a standardized measure of biological and psychological function. JAMA 1963;185:914–919.
  33. Lawton MP, Brody E: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–186.
  34. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, DC, Author, 1994.
  35. Mckhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical-Diagnosis of Alzheimers-Disease – Report of the Nincds-Adrda Work Group Under the Auspices of Department of Health and Human Services Task Force on Alzheimers-Disease. Neurology 1984;34:939–944.
  36. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard R: Camdex – a standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698–709.
  37. Ivanoiu A, Adam S, Van der Linden M, Salmon E, Juillerat A, Mulligan R, Seron X: Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer’s disease. J Neurol 2005;252:47–55.
  38. Shah Y, Tangalos EG, Petersen RC: Mild cognitive impairment. When is it a precursor to Alzheimer’s disease? Geriatrics 2000;55:62, 65–62, 68.
  39. Zubenko GS, Zubenko WN, McPherson S, Spoor E, Marin DB, Farlow MR, Smith GE, Geda YE, Cummings JL, Petersen RC, Sunderland T: A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer’s disease. Am J Psychiatry 2003;160:857–866.
  40. Buschke H, Kuslansky G, Katz M, Stewart WF, Sliwinski MJ, Eckholdt HM, Lipton RB: Screening for dementia with the memory impairment screen. Neurology 1999;52:231–238.
  41. Lindeboom J, Schmand B, Tulner L, Walstra G, Jonker C: Visual association test to detect early dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 2002;73:126–133.
  42. Dierckx E, Engelborghs S, Maertens K, De Deyn PP, Ponjaert-Kristoffersen I: Early differentiation between mild cognitive impairment, Alzheimer’s disease and depression by means of cued recall (abstract). Int Psychogeriatr 2005;17(suppl 2):159–160.
  43. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Int Med 2004;256:183–194.
  44. Andreasen N, Blennow K: CSF biomarkers for mild cognitive impairment and early Alzheimer’s disease. Clin Neurol Neurosurg 2005;107:165–173.
  45. Hänninen T, Hallikainen M, Tuomainen S, Vanhanen M, Soininen H: Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand 2002;106:148–154.
  46. Chen P, Ganguli M, Mulsant BH, DeKosky ST: The temporal relationship between depressive symptoms and dementia. Arch Gen Psychiatry 1999;56:261–266.
  47. Portella MJ, Marcos T, Rami L, Navarro V, Gasto C, Salamero M: Residual cognitive impairment in late-life depression after 12-month follow-up. Int J Geriatr Psychiatry 2003;18:571–576.
  48. Taylor WD, Wagner HR, Steffens DC: Greater depression severity associated with less improvement in depression-associated cognitive deficits in older subjects. Am J Geriatr Psychiatry 2002;10:632–635.
  49. Boustani M, Watson L: The interface of depression and dementia. Psychiatr Times 2004;21:1–8.
  50. Steffens DC, Otey E, Alexopoulos GS, Butters MA, Cuthbert B, Ganguli M, Geda YE, Hendrie HC, Krishnan RR, Kumar A, Lopez OL, Lyketsos CG, Mast BT, Morris JC, Norton MC, Peavy GM, Petersen RC, Reynolds CF, Salloway S, Welsh-Bohmer KA, Yesavage J: Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry 2006;63:130–138.
  51. Geerlings MI, Schoevers RA, Beekman AT, Jonker C, Deeg DJ, Schmand B, Ader HJ, Bouter LM, Van TW: Depression and risk of cognitive decline and Alzheimer’s disease. Results of two prospective community-based studies in The Netherlands. Br J Psychiatry 2000;176:568–575.
  52. Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D: Depression as a risk factor for Alzheimer’s disease. Arch Neurol 2003;60:753–759.
  53. Duara R, Luis C, Barker W, Acevedo A, Loewenstein D: Conversion rates among subgroups of mild cognitive impairment (abstract). Neurobiol Aging 2002;23:S155.
  54. Modrego PJ, Ferrandez J: Depression in patients with mild cognitive impairment increases the risk of developing dementia of the Alzheimer type. Arch Neurol 2004;61:1290–1293.
  55. Migliorelli R, Teson A, Sabe L, Petracchi M, Leiguarda R, Starkstein SE: Prevalence and correlates of dysthymia and major depression among patients with Alzheimer’s disease. Am J Psychiatry 1995;152:37–44.
  56. Vinkers DJ, Gussekloo J, Stek ML, Westendorp RGJ, van der Mast RC: Temporal relation between depression and cognitive impairment in old age: prospective population based study. BMJ 2004;329:881–883.
  57. Videbech P, Ravnkilde B, Fiirgaard B, Clemmensen K, Egander A, Rasmussen NA, Christensen T, Sangill R, Rosenberg R: Structural brain abnormalities in unselected in-patients with major depression. Acta Psychiatr Scand 2001;103:282–286.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50